U.S. markets closed
  • S&P Futures

    4,599.25
    +9.25 (+0.20%)
     
  • Dow Futures

    35,298.00
    +86.00 (+0.24%)
     
  • Nasdaq Futures

    15,856.50
    +13.75 (+0.09%)
     
  • Russell 2000 Futures

    2,211.40
    +7.80 (+0.35%)
     
  • Crude Oil

    70.03
    +0.54 (+0.78%)
     
  • Gold

    1,778.80
    -0.70 (-0.04%)
     
  • Silver

    22.29
    +0.03 (+0.12%)
     
  • EUR/USD

    1.1294
    +0.0008 (+0.07%)
     
  • 10-Yr Bond

    1.4340
    +0.0910 (+6.78%)
     
  • Vix

    27.18
    -3.49 (-11.38%)
     
  • GBP/USD

    1.3282
    +0.0022 (+0.16%)
     
  • USD/JPY

    113.5310
    +0.0410 (+0.04%)
     
  • BTC-USD

    50,845.98
    +1,739.23 (+3.54%)
     
  • CMC Crypto 200

    1,313.41
    +53.25 (+4.23%)
     
  • FTSE 100

    7,232.28
    +109.96 (+1.54%)
     
  • Nikkei 225

    28,282.01
    +354.64 (+1.27%)
     

Recap: Aesthetic Medical Q3 Earnings

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

 

Shares of Aesthetic Medical Intl (NASDAQ:AIH) moved higher by 3.1% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share came in at $(0.04) down from $(0.02) yera-over-year.

Revenue of $41,434,000 higher by 24.49% year over year, which beat the estimate of $37,960,000.

Looking Ahead

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

How To Listen To The Conference Call

Date: Nov 30, 2020

View more earnings on AIH

Time: 08:00 AM

ET Webcast URL: https://78449.choruscall.com/dataconf/productusers/aih/mediaframe/42130/indexr.html

Technicals

Company's 52-week high was at $10.66

52-week low: $3.81

Price action over last quarter: Up 40.94%

Company Description

Aesthetic Medical International Holdings Group Ltd provides aesthetic medical services in China. The company generates revenue from three service offerings: non- surgical aesthetic medical services, comprising minimally invasive aesthetic treatments and energy-based treatments; surgical aesthetic medical services, and general healthcare services and other aesthetic medical services. Most of the firm's revenue gets derived from Non-surgical aesthetic medical services. Geographically, it derives revenue from China.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.